Co-Diagnostics, Inc. (CODX): Company Projected Revenue

Brandmark of Co-Diagnostics Corp (CODX)

The future sales revenue chart for Co-Diagnostics, Inc. (CODX) is based on recurring payments for the CoPrimer PCR platform, ensuring a stable cash flow, where the value 0.00 represents the current amount. Operational resilience is supported by external logistics outsourcing, while scaling potential is linked to the launch of the Co-Dx PCR Home system and expansion into emerging markets.

CoDx - CODX Company Sales Forecast (period 07/04/2022 - 11/15/2026)

Analytical breakdowns and data insights for company Co-Diagnostics Corp (CODX)

- stock quotes and analyst forecast:
Comprehensive company analysis:codiagnostics.com
Brand item of Co-Diagnostics Inc

This indicator reflects the company's expected revenue, serving as the basis for calculating forward valuation multiples. The metric synthesizes financial reporting data and market expectations, reacting to any changes in product adoption rates. By analyzing the projected future sales figure, an investor determines the asset's potential for capitalization growth. For Co-Diagnostics, Inc. (CODX), the curve's dynamics reflect the success of the transition to new diagnostic solutions. The updating of the Co-Primers test line for the agricultural and medical sectors directly determines the trajectory of this value.

Competitor analysis

Company Projected Revenue Agilent (A)|Projected Sales Volume Quest Diagnostics Incorporated (DGX)|Company Projected Revenue Illumina Corp ILMN|EXAS: Company Revenue Forecast|RVTY: Company Future Sales Volume|Company Sales Forecast bio-rad.com (BIO)|NNNN: Projected Sales Volume|Sotera Health - Company Future Revenue|QDEL (quidel.com) - Projected Sales Volume|OPK: Company Future Revenue|Company Future Sales Volume CDNA (CareDx)|Projected Sales Volume Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Company Future Sales Volume|LAB: Company Revenue Forecast|Cytek Corp - Projected Sales Volume|Company Future Revenue OSUR (OraSure Technologies)|XGN: Projected Sales Volume|MDxHealth - Company Future Revenue|LUCD (luciddx.com) - Projected Sales Volume|PRE - Company Sales Forecast|Company Projected Revenue Insight Molecular Diagnostics Inc (IMDX)|TRIB - Company Expected Sales Volume|Projected Sales Volume PRPH (ProPhase Labs, Inc.)|Company Future Sales ainos.com (AIMD)|heartsciences.com - Projected Sales Volume|Biomerica, Inc (BMRA) - Company Future Sales Volume|Cardio Diagnostics (CDIO) - Company Projected Revenue|ONCO - Company Future Sales|VRAX (Virax Biolabs Corp) - Projected Sales Volume|Bluejay Diagnostics, Inc. (BJDX) - Company Future Sales|Projected Sales Volume AWH|Accelerate Diagnostics Inc. - Company Revenue Forecast|Centogene - Company Future Sales Volume|Enzo Biochem, Inc. (ENZ) - Company Expected Sales Volume|Company Projected Revenue Volume Fresh2 Group Limited FRES|Company Future Sales gtglabs.com GENE|23andMe Holding Co (ME) - Company Projected Revenue|Company Revenue Forecast PMD